{
    "2019-08-20": [
        [
            {
                "time": "2018-09-10",
                "original_text": "Bayer Sells Animal Health Division to Elanco: Now What?",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Animal Health Division",
                        "Elanco",
                        "sale"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "IXJ, LLY, ABBV, DHR: Large Outflows Detected at ETF",
                "features": {
                    "keywords": [
                        "IXJ",
                        "LLY",
                        "ABBV",
                        "DHR",
                        "ETF",
                        "outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "Breaking down the debate for medicare for all",
                "features": {
                    "keywords": [
                        "medicare",
                        "debate",
                        "policy"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-13",
                "original_text": "UPDATE 3-Elanco to become No.2 in animal health with $7.6 bln Bayer deal",
                "features": {
                    "keywords": [
                        "Elanco",
                        "animal health",
                        "Bayer",
                        "deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}